Fraune, Christoph <br/><br/>
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion.  [electronic resource] 

 -  Molecular medicine (Cambridge, Mass.)  03 2020 
 - 24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-3658 
<br/><br/><label>Standard No.: </label>10.1186/s10020-020-00148-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Chromosome Deletion<br/>Gene Expression Profiling--methods<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Lymphatic Metastasis<br/>Male<br/>Margins of Excision<br/>Middle Aged<br/>Neoplasm Staging<br/>Oncogene Proteins, Fusion--metabolism<br/>Prognosis<br/>Prostatic Neoplasms--genetics<br/>Tissue Array Analysis<br/>Transcription Factor AP-2--metabolism<br/>Up-Regulation